Cullinan Therapeutics (CGEM) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

12.020
-0.880-6.82%

Close Dec 27 16:00 ET

12.020
0.0000.00%

Post 16:20 ET

699.90MMarket Cap-4.23P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: President and CEO of $CGEM (CGEM) Sells 8,400 Shares
Quiver Quantitative18:15 ET
Clear Street Launches Healthcare & Biotechnology Equity Research
BusinesswireDec 17 14:00 ET
Top Premarket Decliners
MT NewswiresDec 16 07:51 ET
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaDec 12 08:54 ET
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
TipRanksNov 20 22:58 ET
We're Not Very Worried About Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Rate
Simply Wall StNov 19 11:22 ET

Comments

Jaguar8

Oct 16 06:38

NEWS

$Cullinan Therapeutics (CGEM.US)$
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
Cullinan Therapeutics (Nasdaq: CGEM) announced FDA clearance of its Investigational New Drug (IND) Application for CLN-978, allowing its global Phase 1 clinical trial to proceed in the U.S. for patients with moderate to severe systemic lupus erythematosus (SLE). CLN-9...

Jaguar8

Apr 24 09:10

$Cullinan Therapeutics (CGEM.US)$
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Moomoo Breakfast US

May 12, 2022 07:18

Columns Today's pre-market stock movers: BYND, DIS, F, GM and more

Gainers:
• $Cullinan Therapeutics (CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors (RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin (APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent (SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang (CPNG.US)$ +14.3%(In reaction to earn...

OldNormanBates

Jan 6, 2021 05:38

$Cullinan Therapeutics (CGEM.US)$ ISO this week in Biotech Pharma.

Heat List

Overall

No Data